report Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature

被引：9
作者：
Siddiqa, Ayesha [1 ,2 ]
Khan, Shanza [1 ,2 ]
Rodriguez, George D. [1 ,3 ,4 ]
Urban, Carl [1 ,2 ,5 ]
-Maurer, Sorana Segal [1 ,2 ,5 ]
Turett, Glenn [1 ,2 ]
机构：
[1] NewYork Presbyterian Queens, Dept Med, 56-45 Main St, Flushing, NY 11355 USA
[2] NewYork Presbyterian Queens, Dr James J Rahal Jr Div Infect Dis, Dr, 56-45 Main St, Flushing, NY 11355 USA
[3] NewYork Presbyterian Queens, Div Antimicrobial Stewardship, 56-45 Main St, Flushing, NY 11355 USA
[4] Columbia Univ, Columbia Univ Sch Nursing, New York, NY 10032 USA
[5] Cornell Univ, Weill Cornell Med Coll, Ithaca, NY 10065 USA
来源：
IDCASES | 2023年 / 31卷
关键词：
Mycobacterium abscessus; Omadacycline; Therapy; Synergy; SKIN;
D O I：
10.1016/j.idcr.2023.e01703
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Treatment of Mycobacterium abscessus infections are problematic due to inherent multidrug resistance and lack of response to antibacterials commonly used as therapy for other mycobacterial infections. We report the clinical success of five patients who received definitive-treatment with an omadacycline-containing combination regimen for M. abscessus infection.
引用
收藏
页数：4
相关论文
共 20 条
  • [1] Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
    Bax, Hannelore I.
    de Vogel, Corne P.
    Mouton, Johan W.
    de Steenwinkel, Jurriaan E. M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (10) : 2930 - 2933
  • [2] Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
    Bich Hanh, Bui Thi
    Quang, Nguyen Thanh
    Park, Yujin
    Heo, Bo Eun
    Jeon, Seunghyeon
    Park, June-Woo
    Jang, Jichan
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease
    Chen, Jianhui
    Zhao, Lan
    Mao, Yanhua
    Ye, Meiping
    Guo, Qi
    Zhang, Yongjie
    Xu, Liyun
    Zhang, Zhemin
    Li, Bing
    Chu, Haiqing
    [J]. FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [4] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
    Daley, Charles L.
    Iaccarino, Jonathan M.
    Lange, Christoph
    Cambau, Emmanuelle
    Wallace, Richard J., Jr.
    Andrejak, Claire
    Bottger, Erik C.
    Brozek, Jan
    Griffith, David E.
    Guglielmetti, Lorenzo
    Huitt, Gwen A.
    Knight, Shandra L.
    Leitman, Philip
    Marras, Theodore K.
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Tortoli, Enrico
    van Ingen, Jakko
    Wagner, Dirk
    Winthrop, Kevin L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : E1 - E36
  • [5] Dupont C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01225-17, 10.1128/aac.01225-17]
  • [6] Omadacycline: A Modernized Tetracycline
    Gallagher, Jason C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 : S1 - S5
  • [7] Kaushik A, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00470-19, 10.1128/aac.00470-19]
  • [8] A Case of Skin and Soft Tissue Infection Caused by Mycobacterium abscessus
    Kwon, Yong Hyun
    Lee, Ga-Young
    Kim, Won-Serk
    Kim, Kea Jeung
    [J]. ANNALS OF DERMATOLOGY, 2009, 21 (01) : 84 - 87
  • [9] Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
    Lindman, Marissa
    Dick, Thomas
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [10] Utilizing the Promise of Omadacycline in a Resistant, Non-tubercular Mycobacterial Pulmonary Infection
    Minhas, Ramandeep
    Sharma, Shaurya
    Kundu, Suhali
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
12